Home Use of Mechanical Insufflation/Exsufflation Devices in Neuromuscular Diseases

NCT04729920 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2021-02-03

No results posted yet for this study

Summary

With this cross-sectional study of adult subjects with neuromuscular disease in the French-speaking part of Switzerland, we aim to explore MI-E adherence using self-report questionnaires and device data in order to identify the factors that influence the pattern of MI-E use and satisfaction with the treatment. Determining potential barriers to regular long-term home use of MI-E could help in identifying the patients who would benefit most from this therapy.

Conditions

Interventions

DEVICE

Mechanical insufflation/exsufflation device (MI-E)

download of device (MI-E) data and self-reported satisfaction with the device

Sponsors & Collaborators

  • Ligue Pulmonaire Vaudoise

    collaborator UNKNOWN
  • University Hospital, Geneva

    collaborator OTHER
  • Centre Hospitalier Universitaire Vaudois

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-15
Primary Completion
2020-05-01
Completion
2020-05-01
FDA Device
Yes

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04729920 on ClinicalTrials.gov